The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence and survival trends in small bowel adenocarcinoma (SBA) from 2000-2019 in the United States.
 
James Sears
No Relationships to Disclose
 
Yifei Xu
No Relationships to Disclose
 
Jingxia Liu
No Relationships to Disclose
 
Mark Fiala
No Relationships to Disclose
 
Robert McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
Michael Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Eisai; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Roche/Genentech; Simcere
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Katrina Pedersen
Honoraria - OncLive/MJH Life Sciences; Takeda; WebMD/Medscape; WebMD/Medscape (Inst)
Consulting or Advisory Role - Agenus; Array BioPharma; Artemida Pharma; AstraZeneca; Bayer; Bristol Myers Squibb; GlaxoSmithKline; Guardant Health; Incyte; Novartis; Pfizer; SAGA Diagnostics; Taiho Oncology; Taiho Oncology; Takeda (Inst); Tempus
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Biomea Fusion (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); Daiichi Sankyo/Lilly (Inst); HCW Biologics (Inst); Incyte (Inst); Ipsen (Inst); Natera (Inst); Nouscom (Inst); Novartis (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene; GlaxoSmithKline; NCCN; Nouscom
Other Relationship - UpToDate
(OPTIONAL) Uncompensated Relationships - NCCN